-
161
Antidepressant Prophylaxis Reduces Depression Risk but Does Not Improve Sustained Virological Response in Hepatitis C Patients Receiving Interferon Without Depression at Baseline: A Systematic Review and Meta-Analysis
Published 2013-01-01“…BACKGROUND: Depression complicates interferon-based hepatitis C virus (HCV) antiviral therapy in 10% to 40% of cases, and diminishes patient well-being and ability to complete a full course of therapy. …”
Get full text
Article -
162
RNA N6‐Methyladenosine‐Binding Protein YTHDFs Redundantly Attenuate Cancer Immunity by Downregulating IFN‐γ Signaling in Gastric Cancer
Published 2025-01-01Subjects: Get full text
Article -
163
-
164
Non-Melanoma Skin Cancer Aggravation in Polycythemia Vera: Triggered by Ruxolitinib and Silenced With an IFN/Cemiplimab
Published 2025-01-01Subjects: Get full text
Article -
165
Employing the Oncolytic Vesicular Stomatitis Virus in Cancer Virotherapy: Resistance and Clinical Considerations
Published 2024-12-01Subjects: Get full text
Article -
166
Host–virus interactions during infection with a wild-type ILTV strain or a glycoprotein G deletion mutant ILTV vaccine strain in an ex vivo system
Published 2025-02-01Subjects: Get full text
Article -
167
-
168
-
169
Increased interferon I signaling, DNA damage response and evidence of T-cell exhaustion in a patient with combined interferonopathy (Aicardi-Goutières Syndrome, AGS) and cohesinopathy (Cornelia de Lange Syndrome, CdLS)
Published 2025-01-01“…Conclusions A rare case of a patient bearing two genetic lesions (responsible for AGS/CdLS syndromes) exhibits distinctive features of genomic damage and interferon responses. Immune phenotype revealed granulocytic skewing and absence of activated T cells compatible with chronic antigenic stimulation and/or homing of these cells at sites of inflammation.…”
Get full text
Article -
170
Psychometric Validation of the Hepatitis C Symptom and Impact Questionnaire (HCV-SIQv4) in a Diverse Sample of Adults with Chronic Hepatitis C Virus Infection Treated with an Interferon-free Simeprevir-containing Regimen
Published 2019-02-01“…**Methods:** PRO data were pooled from three Phase IIb and III trials evaluating interferon-free simeprevircontaining regimens for treatment of chronic HCV infection. …”
Get full text
Article -
171
Biochemical Evolution and Histological Response of Patients with Hepatitis C Undergoing Antiviral Therapy.
Published 2011-07-01Subjects: Get full text
Article -
172
Therapeutic potential of targeting the IRF2/POSTN/Notch1 axis in nucleus pulposus cells for intervertebral disc degeneration
Published 2025-01-01Subjects: Get full text
Article -
173
IFN-γ/TNF-α Synergism Induces Pro-Inflammatory Cytokine and Chemokine Production by In Vitro Canine Keratinocytes
Published 2025-01-01Subjects: Get full text
Article -
174
-
175
Inhibition of STING-mediated type I IFN signaling by African swine fever virus DP71L
Published 2025-02-01Subjects: Get full text
Article -
176
Mendelian Susceptibility to Mycobacterial Diseases (MSMD) in a 13-Year-Old Ethiopian Girl with Autosomal Dominant Interferon Gamma Receptor 1(IFN-γ R1) Defect: A Clinical Diagnostic and Treatment Challenge
Published 2022-01-01“…Treatments constitute antimycobacterial, interferon-gamma, surgery, and hematopoietic stem cell transplantation (HSCT), which is the only known curative treatment. …”
Get full text
Article -
177
Intricating connections: the role of ferroptosis in systemic lupus erythematosus
Published 2025-02-01Subjects: Get full text
Article -
178
Efficacy and safety of new protease inhibitor faldaprevir in treatment of hepatitis C
Published 2013-12-01Subjects: “…treatment modes without interferon…”
Get full text
Article -
179
The effect of interleukin-10 and transforming growth factor β-1 on HLA-DR expression in colonic epithelial cells
Published 1998-01-01Subjects: Get full text
Article -
180
Decoding mitochondrial DNA damage and repair associated with H. pylori infection
Published 2025-01-01Subjects: Get full text
Article